Barack Obama's Meeting With Chinese President Bodes Well For Pan-Pacific Pharma Partnerships, Says Analyst During Shanghai Conference
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Despite the financial maelstrom that has lashed economies from the Americas to Asia, U.S. President Barack Obama's April 1 meeting with Chinese President Hu Jintao is ultimately likely to boost the pharmaceutical sector in each country and the potential for pan-Pacific partnerships, according to the chief executive officer of the San Diego-based consulting firm BioForesight
You may also be interested in...
Chinese President Pledges China Will Not Discriminate Against U.S. Businesses; Broad Healthcare Partnership Unveiled
WASHINGTON, D.C. - In introducing China President Hu Jintao at a luncheon reception Jan. 20, former Secretary of State Henry Kissinger said that if China and the U.S. work together most of the problems between the two nations "will find a creative solution," but if the two nations can't do that, then "there is no possibility for one side or the other achieving a success over the other.
Chinese President Pledges China Will Not Discriminate Against U.S. Businesses; Broad Healthcare Partnership Unveiled
WASHINGTON, D.C. - In introducing China President Hu Jintao at a luncheon reception Jan. 20, former Secretary of State Henry Kissinger said that if China and the U.S. work together most of the problems between the two nations "will find a creative solution," but if the two nations can't do that, then "there is no possibility for one side or the other achieving a success over the other.
Chinese President Pledges China Will Not Discriminate Against U.S. Businesses; Broad Healthcare Partnership Unveiled
The public-private partnership includes Pfizer, Johnson & Johnson, Abbott, Medtronic, General Electric, Chindex and Microsoft.